Sinil Pharmaceutical Statistics

Total Valuation

Sinil Pharmaceutical has a market cap or net worth of KRW 72.81 billion. The enterprise value is 40.83 billion.

Market Cap	72.81B
Enterprise Value	40.83B

Important Dates

The next estimated earnings date is Wednesday, March 5, 2025.

Earnings Date	Mar 5, 2025
Ex-Dividend Date	n/a

Share Statistics

Sinil Pharmaceutical has 11.38 million shares outstanding. The number of shares has decreased by -0.12% in one year.

Current Share Class	n/a
Shares Outstanding	11.38M
Shares Change (YoY)	-0.12%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	34.48%
Owned by Institutions (%)	0.70%
Float	7.45M

Valuation Ratios

The trailing PE ratio is 4.91.

PE Ratio	4.91
Forward PE	n/a
PS Ratio	0.81
PB Ratio	0.52
P/TBV Ratio	0.51
P/FCF Ratio	3.25
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 1.93, with an EV/FCF ratio of 1.82.

EV / Earnings	2.71
EV / Sales	0.45
EV / EBITDA	1.93
EV / EBIT	2.71
EV / FCF	1.82

Financial Position

The company has a current ratio of 5.00, with a Debt / Equity ratio of 0.00.

Current Ratio	5.00
Quick Ratio	3.51
Debt / Equity	0.00
Debt / EBITDA	0.02
Debt / FCF	0.02
Interest Coverage	679.92

Financial Efficiency

Return on equity (ROE) is 10.98% and return on invested capital (ROIC) is 6.86%.

Return on Equity (ROE)	10.98%
Return on Assets (ROA)	6.10%
Return on Capital (ROIC)	6.86%
Revenue Per Employee	319.51M
Profits Per Employee	52.49M
Employee Count	287
Asset Turnover	0.59
Inventory Turnover	2.20

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -15.12% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-15.12%
50-Day Moving Average	6,857.20
200-Day Moving Average	7,202.70
Relative Strength Index (RSI)	41.66
Average Volume (20 Days)	21,365

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Sinil Pharmaceutical had revenue of KRW 91.70 billion and earned 15.07 billion in profits. Earnings per share was 1,303.47.

Revenue	91.70B
Gross Profit	40.03B
Operating Income	15.09B
Pretax Income	17.40B
Net Income	15.07B
EBITDA	21.14B
EBIT	15.09B
Earnings Per Share (EPS)	1,303.47

Full Income Statement

Balance Sheet

The company has 32.45 billion in cash and 470.13 million in debt, giving a net cash position of 31.98 billion or 2,810.76 per share.

Cash & Cash Equivalents	32.45B
Total Debt	470.13M
Net Cash	31.98B
Net Cash Per Share	2,810.76
Equity (Book Value)	143.32B
Book Value Per Share	12,398.15
Working Capital	58.21B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 26.37 billion and capital expenditures -3.97 billion, giving a free cash flow of 22.40 billion.

Operating Cash Flow	26.37B
Capital Expenditures	-3.97B
Free Cash Flow	22.40B
FCF Per Share	1,968.83

Full Cash Flow Statement

Margins

Gross margin is 43.65%, with operating and profit margins of 16.45% and 16.43%.

Gross Margin	43.65%
Operating Margin	16.45%
Pretax Margin	18.97%
Profit Margin	16.43%
EBITDA Margin	23.06%
EBIT Margin	16.45%
FCF Margin	24.43%

Dividends & Yields

This stock pays an annual dividend of 170.00, which amounts to a dividend yield of 2.66%.

Dividend Per Share	170.00
Dividend Yield	2.66%
Dividend Growth (YoY)	70.00%
Years of Dividend Growth	3
Payout Ratio	13.04%
Buyback Yield	0.12%
Shareholder Yield	2.78%
Earnings Yield	20.37%
FCF Yield	30.76%

Dividend Details

Stock Splits

The last stock split was on December 28, 2022. It was a forward split with a ratio of 1.04.

Last Split Date	Dec 28, 2022
Split Type	Forward
Split Ratio	1.04

Scores

Sinil Pharmaceutical has an Altman Z-Score of 5.41.

Altman Z-Score	5.41
Piotroski F-Score	n/a